SCHEMBL3259535

SCHEMBL3259535

C=CCC1(CC=C)COc2ccccc2C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
HSP90AA1 P07900 1/20 0.36
MAOB P27338 10/20 0.35
CYP19A1 P11511 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
MIF P14174 1/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL87287 0.80 MAOB (0.40) HTTMAOBCYP19A1CYP3A4CYP2C19
SCHEMBL9286065 0.73 LMNA (0.65) NPSR1LMNAHTTL3MBTL1TSHR
SCHEMBL4618757 0.73 TSHR (0.47) NPSR1L3MBTL1PKMTSHRMAOB
SCHEMBL11386178 0.73 PKM (0.38) NPSR1LMNAHTTL3MBTL1PKM
SCHEMBL2156976 0.73 APEX1 (0.44) NPSR1LMNAHTTL3MBTL1PKM
SCHEMBL11382497 0.72 PKM (0.40) NPSR1PKMTSHRMAOBCYP19A1
SCHEMBL2156979 0.71 PRKCA (0.44) LMNAPKMTSHRALDH1A1CYP3A4
SCHEMBL9136839 0.69 PKM (0.47) NPSR1PKMTSHRMAOBCYP19A1
SCHEMBL29448029 0.69 PKM (0.47) NPSR1LMNAL3MBTL1PKMTSHR
SCHEMBL4618755 0.69 TSHR (0.47) NPSR1L3MBTL1PKMTSHRMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7671220-B2 Processes for the 3,3-dialkylation of 4-chromanones WYETH (US) 2010-03-02 US disclosed
WO-2006089008-A2 PROCESSES FOR THE 3,3-DIALKYLATION OF 4-CHROMANONES WYETH (US) 2006-08-24 WO disclosed
US-20060183924-A1 Processes for the 3,3-dialkylation of 4-chromanones WYETH (US) 2006-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183924-A1 Processes for the 3,3-dialkylation of 4-chromanones GCK, KHK, CDYL NPSR1 4252/4885LMNA 2407/4885HTT 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.